Fraki J E, Lazarus G S, Gilgor R S, Marchase P, Singer K H
Br J Dermatol. 1983 Jan;108(1):39-44. doi: 10.1111/j.1365-2133.1983.tb04577.x.
The specific activity of plasminogen activator was increased in clinically involved psoriatic epidermis compared with the uninvolved skin of the same eight patients. Alterations in plasminogen activator activity correlated with disease activity as measured by extent of body surface involved with psoriasis. Levels of plasminogen activator increased in uninvolved epidermis of psoriatic patients during retinoid therapy.
与同一8例患者未受累皮肤相比，临床受累的银屑病表皮中纤溶酶原激活剂的比活性增加。纤溶酶原激活剂活性的改变与通过银屑病累及的体表面积衡量的疾病活动相关。在维甲酸治疗期间，银屑病患者未受累表皮中的纤溶酶原激活剂水平升高。
